Caminemos! Trial to Increase Walking Among Sedentary Older Latinos

May 16, 2012 updated by: National Institute on Aging (NIA)

Trial to Increase Walking Among Sedentary Older Latinos

The purpose of this study is to examine the efficacy of a multifaceted behavioral intervention aimed at raising walking levels among sedentary older Latinos.

Study Overview

Detailed Description

Regular physical activity contributes to the health and quality of life of older adults, but unfortunately only 20% of men and 25% of women aged 65 years and greater meet the minimal national guidelines for physical activity. Older Latinos have higher rates of diseases that are most likely to benefit from physical activity, but have disproportionately high rates of sedentary lifestyle. To address this major public health problem, this study will implement and evaluate a multifaceted intervention to raise and sustain walking levels among older Latinos.

A total of 600 sedentary older Latinos will be recruited from community-based senior centers in the greater Los Angeles region. The specific aims of the study are to test the effect of the intervention on:

  1. the change in steps per week measured by digital pedometer from baseline to 1, 12, and 24-month follow-up;
  2. self-reported physical activity level and intervening constructs (including expectations regarding aging and self-efficacy expectations for physical activity);
  3. psychosocial health constructs, physical performance measures, and clinical health outcomes.

The core of the intervention consists of a series of 4 weekly 1-hour group discussion sessions that utilize attribution retraining techniques from the field of motivational psychology in combination with behavioral strategies based in social cognitive theory. Discussion sessions will be conducted at senior centers and led by a bilingual health educator; each session will be followed by a 1-hour exercise class aimed at increasing strength, flexibility and endurance. During the discussion sessions, the health educator will administer a structured culturally-tailored curriculum in which participants are taught to raise their expectations for physical activity with aging and not to attribute being sedentary to "old age." The 4 weekly sessions will be followed by monthly sessions for 11 months, and sessions every 2 months for the following 12 months (total intervention duration = 24 months). Participants will be randomized to 1 of 2 arms:

  1. intervention arm: receiving the discussion session and the exercise class;
  2. control arm: receiving just the exercise class with the same frequency and duration as the intervention group.

Study Type

Interventional

Enrollment (Anticipated)

600

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90095
        • UCLA Division of Geriatrics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 60 years or older
  • Self-identifying as Latino/Hispanic
  • Not currently participating in 20 minutes or more of physical activity 3 times a week
  • Willingness to take brief physical activity screening test and if do not pass, provide the name of a physician who has seen the patient in the recent past

Exclusion Criteria:

  • Plans to move from the area in the next 24 months
  • Unable to participate in 1-hour group discussion
  • Unable to walk
  • Physician stating that patient is not medically able to participate
  • Family member already participating
  • Substantial cognitive impairment (determined by a screening test)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
discussion session and exercise class
A series of 4 weekly 1-hour group discussion sessions that utilize attribution retraining techniques from the field of motivational psychology in combination with behavioral strategies based in social cognitive theory; weekly for 4 weeks, monthly for 11 months, then every two months for 12 months (total duration = 24 months
1-hour exercise class aimed at increasing strength, flexibility and endurance; weekly for 4 weeks, monthly for 11 months, then every two months for 12 months (total duration = 24 months
Active Comparator: 2
exercise class only
1-hour exercise class aimed at increasing strength, flexibility and endurance; weekly for 4 weeks, monthly for 11 months, then every two months for 12 months (total duration = 24 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of steps per week on digital pedometer
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months

Secondary Outcome Measures

Outcome Measure
Time Frame
Self-reported physical activity level
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
beliefs about aging
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
self-efficacy
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
health-related quality of life
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
blood pressure
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
body mass index (BMI)
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
physical performance measures
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
hospital days
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
outpatient visits
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
restricted activity days
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months
cognitive function
Time Frame: baseline and 1, 12, and 24-months
baseline and 1, 12, and 24-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catherine Sarkisian, MD, MSPH, UCLA Division of Geriatrics

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2005

Primary Completion (Actual)

August 1, 2009

Study Completion (Actual)

August 1, 2009

Study Registration Dates

First Submitted

September 13, 2005

First Submitted That Met QC Criteria

September 13, 2005

First Posted (Estimate)

September 16, 2005

Study Record Updates

Last Update Posted (Estimate)

May 18, 2012

Last Update Submitted That Met QC Criteria

May 16, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • AG0049
  • 5R01AG024460-02 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe